Sirona Biochem Announces Results Of Shareholder Meeting

Vancouver, British Columbia – August 25, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (FRANKFURT: ZSB) is pleased to announce that all resolutions tabled at its Annual General and Special Meeting held on August 21, 2015, were passed. The resolutions included:

- Election of Casper Bych, Géraldine Deliencourt-Godefroy, Martin Gleave, Christopher Hopton, Alex Marazzi, David Moore, and Howard Verrico as directors;

- Appointment of auditor and authorization of the directors to fix the auditor’s remuneration; and

- Adoption of a 2015 Stock Option Plan.

Management, with the renewed investor support, continues to advance partnering activity on its novel skin lightener SBM-TFC-1067 and its library of anti-aging compounds. Interest level from prospective partners has exceeded management expectations. An investor update is being planned for the near future.

For more information regarding this press release, please contact:
Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com

Help employers find you! Check out all the jobs and post your resume.

Back to news